EDX Medical Group (LON: EDX) is launching TC100, a highly accurate early detection test for testicular cancer. A blood sample is assessed. There have been more than 30 study reports on the test. The share price improved 17.4% to 13.5p.
BWA Group (LON: BWAP) published an updated inferred mineral resource for the Dehane heavy mineral sands project in Cameroon of 4.2 million tonnes at 3.5% THM cut-off, comprising grades of ilmenite at 0.99%, kyanite at 1.54%, rutile at 0.13% and zircon at 0.11%. There are plans for a fundraising during this year to finance the development of the project. Chairman Jonathan Wearing bought 500,000 shares at 0.2p each and Tricastle Investments, a company he controls, purchased 1.33 million shares at 0.15p each, taking his total stake to 25.85%. The share price rose 16.7% to 0.175p.
Chief executive Paul Mathieson’s stake in Investment Evolution Credit (LON: IEC) has reduced from 35.4% to 29.9%. Michael Rogers has a 4.88% shareholding. The share price increased 14.3% to 4p.
Automotive electrification technology developer Equipmake (LON: EQIP) has received a £368,000 order from Gilmour Space Technologies, which about to launch an Australian orbital rocket later in the year. Equipmake will supply electric motors and inverters. The share price recovered 8.7% to 1.25p.
FALLERS
Unicorn Asset Management’s stake in skincare technology developer Incanthera (LON: INC) from 11.4% to 10.8%.
Valereum (LON: VLRM) says the £19m strategic deal with DMC is nearing completion but the additional £1m subscription by a UK institution will not happen.
Clean fuel additives SulNOx Group (LON: SNOX) says Colas Rail UK is adopting SulNOx Eco following an evaluation. There were sharp falls in emissions and a 4.5% improvement in fuel efficiency. This is the first major contract in the rail sector.